SOLETRA
Report
- Report Number
- 3007566237-2016-03389
- Event Type
- Injury
- Date Received
- September 27, 2016
- Date of Event
- July 20, 2016
- Report Date
- October 9, 2017
- Manufacturer
- MEDTRONIC NEUROMODULATION
- Product Code
- MHY
- PMA / PMN Number
- P960009
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS
- Reporter Occupation
- PHYSICIAN
Narratives
DATE OF EVENT. PLEASE NOTE THAT THIS DATE IS BASED OFF THE DATE OF PUBLICATION OF THE ARTICLE AS THE ACTUAL EVENT DATE WAS NOT PROVIDED. COMMON DEVICE NAME. AND REPORT SOURCE. PLEASE NOTE THAT THIS DEVICE WAS USED IN AN OFF-LABEL MANNER AS IT WAS IMPLANTED FOR EPILEPSY. THE MAIN COMPONENT OF ONE OF THE SYSTEMS INVOLVED IN THE REPORTED EVENTS; OTHER APPLICABLE COMPONENTS ARE: PRODUCT ID: 3389, PRODUCT TYPE: LEAD. (B)(4). A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
UPON FURTHER REVIEW, IT WAS DETERMINED THAT THIS EVENT TYPE WAS AN "ADVERSE EVENT AND PRODUCT PROBLEM". IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
SON, B.C., SHON, Y.M., CHOI, J.G., KIM, J., HA, S., KIM, S-H., LEE, S. CLINICAL OUTCOME OF PATIENTS WITH DEEP BRAIN STIMULATION OF THE CENTROMEDIAN THALAMIC NUCLEUS FOR REFRACTORY EPILEPSY AND LOCATION OF THE ACTIVE CONTACTS. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY. 2016. 94(3):187-197. DOI: 10.1159/000446611 SUMMARY: TO INVESTIGATE THE CLINICAL OUTCOME OF PATIENTS TREATED WITH CHRONIC DEEP BRAIN STIMULATION (DBS) OF THE CENTROMEDIAN NUCLEUS (CM) FOR REFRACTORY EPILEPSY AND TO DETERMINE THE LOCATION OF ACTIVE CONTACTS. REPORTED EVENTS: ONE (B)(6) FEMALE PATIENT WITH BILATERAL CENTROMEDIAN THALAMIC NUCLEUS (CM) DEEP BRAIN STIMULATION (DBS) FOR REFRACTORY EPILEPSY HAD MISPLACEMENT OF THE BILATERAL DBS LEADS DUE TO INTRAOPERATIVE BRAIN SHIFT. THIS NECESSITATED REPLACEMENT. THE PATIENT WENT ON TO HAVE A 60% REDUCTION IN SEIZURE FREQUENCY. THE FOLLOWING DEVICE SPECIFICS WERE PROVIDED IN THE ARTICLE: LEAD MODEL 3389 AND IMPLANTABLE NEUROSTIMULATOR MODEL 7426.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 630949 | SOLETRA | STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR | MHY | MEDTRONIC NEUROMODULATION | 7426 | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 36 YR | Required Intervention |